What changes?
Define the business outcome, the affected stakeholders and how value will be observed.
CYBORIUM FOR CFOs · INDEPENDENT TECHNOLOGY SOURCING
Make technology investment decisions that stand up.
Before approval, renewal or provider selection, see the full commercial shape, challenge the assumptions and give the board a decision record built on evidence, not provider sales narratives.
No CYBORIUM invoice to the client. CYBORIUM does not sell, resell, implement, operate or manage technology. Your organisation selects and contracts directly with the provider.
TECHNOLOGY INVESTMENT GATEEVIDENCE ACTIVE
VALUEBusiness outcome
ECONOMICSTotal commercial shape
DELIVERYAssumptions tested
CONTROLExit and lock-in
COMPARABLEProvider evidence
TRACEABLEDecision rationale
BOARD-READYInvestment narrative
Capitalallocated against business outcomes
Exposurevisible beyond quoted price
Evidencestrong enough to challenge
Accountabilitysupported by a clear record
WHEN TECHNOLOGY AMBITION REACHES THE FINANCE DESK
The approval may be one line. The accountability is not.
A technology proposal can look precise while important commercial realities remain outside the headline number. Finance is still expected to determine whether the investment will create value, whether the provider can deliver and whether the organisation can explain the decision later.
You should not have to defend a technology investment using evidence created only by the providers competing to win it.
01
CEO and board: fund growth, resilience and innovation without losing discipline.
02
CIO and CISO: move transformation and security priorities forward at a realistic pace.
03
Procurement: run a fair, traceable process through a technically complex market.
04
Business units: approve faster while the requirement, usage and benefit assumptions are still moving.
05
Audit and risk: show that governance, third-party exposure and decision controls were considered.
THE FULL ECONOMICS
A quoted price is not the same as the commercial shape of the decision.
CYBORIUM helps bring the cost, scope and delivery assumptions into one comparable view before a preferred provider becomes difficult to unwind.
Decision lens
What the proposal may show
What finance needs to test
Implementation
Project fee and timeline
Dependencies, change load and internal effort
Consumption
Licence or service unit price
Usage growth, minimums and variability
Operations
Support package
Service boundaries, escalation and retained workload
Renewal
Initial term
Indexation, repricing and negotiating leverage
Exit
Contract end date
Transition assistance, portability and lock-in exposure
The objective is not simply a lower price. It is a better-understood investment with fewer commercial blind spots.
THE ASSUMPTION REGISTER
The business case is only as strong as the assumptions it makes visible.
Technology proposals often arrive with a confident total and a clear implementation date. The exposure tends to sit in what has not yet been priced, evidenced or owned. CYBORIUM helps turn those assumptions into questions providers must answer consistently.
Internal capacityPeople, change load and specialist effort required from the organisation
OFTEN UNPRICEDAdoption and productivityBehaviour change, training and benefit realisation dependencies
VALUE DEPENDENCYConsumption growthUsage, data, licence and cloud-volume assumptions beyond year one
COST VARIABILITYProvider deliveryNamed capability, implementation depth and third-party dependencies
EVIDENCE REQUIREDRenewal and exitIndexation, leverage, portability and transition assistance
FUTURE EXPOSUREClarifyThe assumption and accountable owner
TestProvider evidence and commercial treatment
RecordWhat decision owners accepted and why
FIVE INVESTMENT GATES
Before capital is committed, five questions should be answerable.
Each gate strengthens the connection between technology ambition, commercial reality and the decision finance may need to defend.
What is the full cost?
Test implementation, consumption, support, renewal, transition and exit assumptions.
Why this provider?
Compare relevant capability and delivery proof against the same requirement set.
Can it land?
Expose dependencies, internal capacity, integration demands and operating fit.
Can it be explained?
Create a traceable rationale that decision owners can challenge and stand behind.
INDEPENDENT MARKET EVIDENCE
Make unlike provider offers genuinely comparable.
Providers can use similar language while differing materially in delivery model, commercial assumptions, support depth, integration capability and enterprise fit. CYBORIUM structures the requirement and market evaluation so decision owners can see those differences earlier.
The organisation retains control of the requirement, shortlist and final provider decision. CYBORIUM adds market intelligence and evaluation capacity around the internal team.
1
Requirements
One business and technology brief
ALIGNEDOne business and technology brief
2
Delivery capability
Evidence beyond presentation quality
TESTEDEvidence beyond presentation quality
3
Commercial model
Scope, assumptions and exposure
VISIBLEScope, assumptions and exposure
4
Enterprise fit
Operating, governance and support reality
COMPAREDOperating, governance and support reality
5
Decision rationale
Why the selected option fits
RECORDEDWhy the selected option fits
ONE DECISION RECORD
Finance, technology and procurement should not be working from three different truths.
CYBORIUM helps connect the perspectives that determine whether a technology investment is affordable, deliverable and defensible.
Investment discipline
Business case, full economics, affordability, commercial exposure and board narrative.
Technology and risk fit
Architecture, transformation, resilience, security, integration and operating requirements.
Process integrity
Fair evaluation, comparable responses, negotiation discipline and traceable governance.
✓
One requirement set. One evaluation method. One decision record.
A clearer basis for executive challenge before the organisation commits.
WHERE FINANCE SCRUTINY MATTERS
Complex technology categories with long commercial consequences.
CYBORIUM supports sourcing and market evaluation across technology decisions where provider capability, delivery assumptions and commercial structure can materially affect value.
AI platforms and services
Use cases, governance, data dependencies, adoption and value assumptions.
Cloud
Migration, consumption, managed cloud, optimisation and exit considerations.
Cybersecurity
Security capability aligned to business risk, resilience and operating needs.
Managed services
Scope boundaries, service levels, transition, retained effort and accountability.
Enterprise IT
Applications, infrastructure, networks, data and transformation providers.
THE DECISION WINDOW
CYBORIUM creates the most value while the answer can still change.
Independent market intelligence is most useful before a familiar provider becomes the default, before the budget paper carries a single option and before a renewal deadline removes negotiating room.
01
Outcome forming
The business need is clear enough to frame, but the provider market is still open.
HIGHEST LEVERAGE02
Market opening
Requirements, evaluation criteria and relevant provider options can still be shaped.
STRONG LEVERAGE03
Shortlist hardening
Commercial assumptions can still be challenged before preference becomes commitment.
ACT NOW04
Decision fixed
The organisation may have less room to improve coverage, evidence or competitive tension.
LIMITED LEVERAGEIf a technology investment is approaching budget approval, shortlist or renewal, this is the useful moment to involve CYBORIUM.
No new tool. No operational dependency. Independent clarity around the decision already in front of you.
A COMMERCIAL MODEL A CFO SHOULD INTERROGATE
Independent sourcing support. No CYBORIUM invoice to the client.
Transparency matters most where a commercial model could otherwise create doubt. CYBORIUM’s objective is to maximise client outcomes, not remuneration.
Your organisation sets the requirement
Internal decision owners retain control of objectives, governance and approval.
CYBORIUM structures the market evaluation
Requirements, provider comparison and commercial evidence are organised consistently.
Your organisation selects and contracts
The final decision remains yours and the contract is directly with the selected provider.
The successful provider may remunerate CYBORIUM
A modest, capped, success-based fee is governed by independence, transparency and fairness principles.
CYBORIUM does not provide legal advice, audit opinions, compliance certification, investment advice or guaranteed financial returns. It does not replace finance, technology, procurement, risk or legal teams.
THE CFO OUTCOME
A technology decision that remains intelligible after approval.
✓
Clearer capital allocation
Technology ambition connected to business outcomes and decision criteria.
✓
More complete commercial visibility
Cost and exposure assessed beyond the provider’s headline price.
✓
Stronger provider comparison
Relevant options evaluated against consistent evidence.
✓
Better executive alignment
CFO, CIO, CISO and procurement working from one decision view.
✓
Reduced sourcing drag
Specialist market intelligence and evaluation capacity around the internal team.
✓
A more defensible record
Rationale that can support board, audit and stakeholder scrutiny.
CFO DECISION READINESS CHECK
Could this investment withstand a five-minute executive challenge?
Confirm the evidence already available. Leave uncertain signals unchecked. This is not a score or financial assessment. It is a fast way to see where a technology recommendation may still depend on untested assumptions.
Technology investment evidence
Can the decision owners answer each statement with evidence that is independent of provider presentation quality?
0 / 6SIGNALS CONFIRMED
Independent evidence is still forming.
Pressure-test the gapsUnchecked signals indicate where CYBORIUM can add market intelligence, commercial comparison and sourcing discipline before approval.
Private by design: selections stay in your browser and are not submitted or stored.
QUESTIONS CFOs ASK
Clarity before the first conversation.
Does CYBORIUM charge the client?
No. The end client does not receive a CYBORIUM consulting, advisory or project invoice. If the client selects a provider through the process, that successful provider may pay CYBORIUM a modest, capped success-based fee under CYBORIUM’s independence, transparency and fairness principles.
Does provider remuneration compromise independence?
CYBORIUM does not maximise remuneration or direct the final selection. The organisation controls the requirement, shortlist and decision. Providers are compared against the client’s requirements, and the commercial model is explained openly so decision owners can interrogate it.
Does CYBORIUM promise savings or return on investment?
No. CYBORIUM helps expose commercial assumptions, compare providers and strengthen decision evidence. It does not provide investment advice, guarantee savings or promise a financial return.
Does CYBORIUM replace our CIO or procurement team?
No. CYBORIUM adds independent technology market intelligence, structured sourcing capability and evaluation capacity around internal finance, technology, security, procurement, risk and legal teams.
When should a CFO involve CYBORIUM?
Before a shortlist hardens, a renewal loses competitive tension or a preferred provider becomes the assumed answer. Early involvement creates more room to clarify outcomes, test the market and compare the full commercial shape.
Which technology decisions can CYBORIUM support?
Cybersecurity, AI, cloud, managed services, enterprise applications, infrastructure, networks, data and other complex technology provider engagements.
BEFORE THE INVESTMENT IS LOCKED IN
Give finance independent clarity before technology spend becomes a commitment.
Bring CYBORIUM in while the requirement, provider market and commercial shape can still be tested.
